These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1703827

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
    Devergie A, Traineau R, Esperou-Bourdeau H, Ribaud P, Socié G, Richard P, Selimi F, Hirsch I, Gluckman E.
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S89-90. PubMed ID: 8177726
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
    Wu Y, Zou S, Cable R, Dorsey K, Tang Y, Hapip CA, Melmed R, Trouern-Trend J, Wang JH, Champion M, Fang C, Dodd R.
    Transfusion; 2010 Apr; 50(4):776-86. PubMed ID: 19912585
    [Abstract] [Full Text] [Related]

  • 49. Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.
    Schmeiser T, Heit W, Arnold R, Bunjes D, Wiesneth M, Hertenstein B, Hampl W, Heimpel H.
    Klin Wochenschr; 1987 Oct 15; 65(20):967-74. PubMed ID: 2828758
    [Abstract] [Full Text] [Related]

  • 50. [Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients].
    Beelen DW, Neumann MC, Mahmoud HK, Henneberg K, Thraenhart O, Schaefer UW.
    Immun Infekt; 1985 Sep 15; 13(5):229-32. PubMed ID: 2998980
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
    Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W.
    Blood; 1995 Nov 01; 86(9):3598-603. PubMed ID: 7579469
    [Abstract] [Full Text] [Related]

  • 54. [Prevention of infection after bone marrow transplantation].
    Schmeiser T.
    Fortschr Med; 1991 Feb 28; 109(6):155-7. PubMed ID: 1646147
    [Abstract] [Full Text] [Related]

  • 55. [False-positive hepatitis serology after administration of immunoglobulins].
    Strobel E, Schöniger M.
    Dtsch Med Wochenschr; 2006 Jun 09; 131(23):1325-7. PubMed ID: 16761202
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
    Schuler U, Ehninger G.
    Med Klin (Munich); 1992 Oct 09; 87 Suppl 1():30-8. PubMed ID: 1334220
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Experiences with cytomegalovirus hyperimmunoglobulin after bone marrow transplantation].
    Schmitz N, Gassmann W, Rautenberg P, Löffler H.
    Immun Infekt; 1985 Sep 09; 13(5):224-8. PubMed ID: 2998979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.